Skip to main content
Erschienen in: BMC Urology 1/2023

Open Access 01.12.2023 | Research

Can pelvic diameter measurement have an effect on surgical outcomes in radical cystectomy?

verfasst von: Anil Erdik, Haci Ibrahim Cimen, Osman Kose, Omer Faruk Ates, Onur Taydas, Deniz Gul, Hasan Salih Saglam

Erschienen in: BMC Urology | Ausgabe 1/2023

Abstract

Objective

To determine the effectiveness of pelvis diameters in determining postoperative outcomes in men who underwent open radical cystectomy + urinary diversion, it is aimed to predict the factors that may affect the operative difficulty and possible surgical outcomes before the operation.

Methods

A total of 79 radical cystectomy patients operated in our institution with preoperative computed tomography (CT) were included the study. Pelvic dimensions; symphysis angle (SA), upper conjugate, lower conjugate, pelvic depth, apical depth (AD), interspinous distance (ISD), bone femoral width and soft tissue width were measured by preoperative CT. ISD index were defined as ISD/AD. Postoperative outcomes and indicators of operative difficulty were recorded. Regression analyses were used to predict perioperative and postoperative outcomes.

Results

Total of 96 complications were observed in 52 of the 79 patients in ninety days (65,8%) with a mean age of 68.25 years. There were significant correlations between SA and body mass index (BMI) with operative time (p = 0.006, p < 0.001; respectively). For estimated blood loss, there were significant correlations between preoperative hematocrit (p = 0,031). Analysis of multivariate logistic regression revealed that higher Charlson comorbidity index (CCI) and BMI were found to be significant predictors for major complications while CCI, pathological T stage and ISD index are prominent predictors for surgical margin positivity.

Conclusions

Pelvic dimensions are not significant with minor or major complications. However, operative time may be associated with SA. Also, narrow and deep pelvis may increase the risk of positive surgical margins.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12894-023-01277-8.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AD
Apical depth
ASA
American Society of Anesthesiologists
BFW
Bony femoral width
BMI
Body mass index
BC
Bladder cancer
CCI
Charlson comorbidity index
CT
Computed tomography
EBL
Estimated blood loss
HCT
Hematocrit
HS
Hospital stay
ISD
Interspinous distance
LC
Lower conjugate
MRI
Magnetic resonance imaging
OT
Operative time
PD
Pelvic depth
PDI
Pelvic dimension index
PSM
Positive surgical margin
RC
Radical cystectomy
RP
Radical prostatectomy
SW
Soft tissue width
SA
Symphysis angle
SSI
Surgical site infection
UC
Upper conjugate

Introduction

While 70% of patients with newly diagnosed bladder cancer (BC) present with the disease confined to the mucosa (stage Ta, carcinoma in situ) or submucosa (T1), the remaining cases often include BC has invaded the muscle [1]. Today, as in the past, bilateral extended pelvic lymph node dissection and urinary diversion surgery in tandem with radical cystectomy (RC) is the accepted gold standard treatment for muscle-invasive BC [2]. However, perioperative morbidity and mortality increase and continence rates deteriorate after orthotopic urinary diversion in patients who have undergone RC, especially among the elderly [3].
Complications after BC surgery can be classified as early or late and major or minor. A prior study revealed that the most common complications of BC surgery regardless of the patient's age, are ileus and infection-related complications (e.g. fever and pyelonephritis) [4]. Complications can be listed as non-specific (e.g. atelectasis or myocardial infarction), diversion related (e.g. urinary fistula, stoma-related stricture and ureteral stricture), or neurological (e.g. delirium) [5]. Despite surgical and medical advances, RC and urinary diversion are associated with significant postoperative mortality ranging from 4 to 11% within 90 days after surgery [6].
Anatomical variations in pelvic dimensions may play an important role in likelihood of developing operative difficulties and complications during an RC procedure such as radical prostatectomy (RP). These variations may be the cause of a high percentage of negative postoperative outcomes (e.g. major complication or positive surgical margin etc.) and a technically challenging operation. A diagnostic model may be useful in predicting RC needed to predicting RC outcomes.
Thin-section computed tomography (CT) is used to determine a patient’s pelvic dimensions before a RC. The potential advantages of this method of imaging as opposed to others is increased speed, a reduction in distortions due to movement and the need for less contrast material, which reduces the risk of nephrotoxicity fast imaging, image distortions due to movement are reduced, and the amount of contrast material decreases significantly thanks to the speed; reduce the risk of nephrotoxicity.
A number of studies have on the relationship between anatomical pelvic variations and perioperative outcomes and postoperative complications of RP [711]. However, little published information exists on the effects of pelvic dimensions on RC outcomes [12]. To date, no research has shown a link between pelvic dimensions and RC postoperative outcomes. Because the impact of pelvic dimensions on RC postoperative outcomes is not clear, this diagnostic study examined the relationship between pelvic dimensions and the development of operative difficulties and negative postoperative outcomes. This was done through a retrospective examination of the postoperative complications of patients who underwent RC and urinary diversion operations due to high-risk and muscle-invasive BC.

Materials and methods

Data collection, patient characteristics and clinical variables

This single centered, retrospective study was approved by the Institutional Review Board of the Ethics Committee of Sakarya University College of Medicine (Approval Number through 00384, 4 June 2020). The study followed the ethical principles of the Declaration of Helsinki. Informed consent was obtained from all subjects when they were admitted to the hospital.
Inclusion criteria for the study participants included having undergone RC after a diagnosis of high risk or invasive BC in our tertiary referral hospital clinic from September 2014 to March 2020. The first step in the study was to collect data on the paticipants retrospectively, which resulted in the collection of data on 129. Of these, 22 patients lacked computed tomography images taken before the operation, so the data on these patients were excluded from the study. Apical depth (AD) could not be evaluated in 28 female patients, resulting in their exclusion. Ultimately, the study included data from 79 male patients.
The following clinicopathological variables were recorded: complications observed intraoperatively, operative time (OT), estimated blood loss (EBL), transfusion rate and type of diversion. The following postoperative variables were recorded: pathological T stage identified in the pathology report, positive surgical margin (PSM), lymph node involvement, complication rates according to Clavien-Dindo (CD) classification, length of hospital stay (HS), readmission to the hospital within 30 days and mortality within 90 days.

Surgical techniques and follow-up

Each patient had undergone an open radical cystectomy, an extended pelvic lymphadenectomy and an ileal conduit following the standard procedures. Postoperative routine, daily examinations and laboratory and imaging follow-ups had been conducted as standard. The patients had been seen for follow-up care at one and three months after the RC. Readmission status up to 30 days and mortality and complications observed up to the 90th postoperative day were recorded according to the CD scoring system, in which, major complications are defined as grades 3–5 and minor or no complications are defined as grades 0–2.

Computed tomography imaging and pelvic dimensions

Pelvic dimensions were measured by transferring preoperative thin-section CT images of the patients’ pelvises to the KarPACS viewer 3.1.9.314 version programme (Mersin, Turkey, 2020). The images were reviewed by two radiologists blinded to the patients’ characteristics. In cases of disagreement the radiologists sought to reach, a consensus.
The following pelvic parameters were used: the upper conjugate (UC) was defined as the distance from the innermost aspect of the top of the symphysis pubis to the sacral promontory on the midsagittal plane while distance from the lower symphysis pubis to the sacrococcygeal junction on the mid-sagittal plane was defined as the lower conjugate (LC) [12]. The distance between between the promontory and the lower symphysis pubis described the pelvic depth (PD) [12]. The symphysis angle (SA) was described as the angle between the long axis of the symphysis and the horizontal midsagittal plane while the distance between the highest point of the symphysis to the prostatic apex was described as the apical depth (AD) [12]. The interspinous distance (ISD) was measured on the axial plane between the tips of the ischial spines. Bony femoral width (BFW) was measured as of the pelvis at the mid-femoral head level on the axial plane while the narrowest distance between the levator muscles was measured as soft tissue width (SW) [12]. All pelvic dimensions in this study are shown in ‘Fig. 1’. BFW, ISD and SW indexes were described as BFW/AD, ISD/AD and SW/AD, respectively [12]. Following the measurement of the patients’ pelvic dimensions the effects of these measurements on surgical and postoperative outcomes were assessed.

Statistical analysis

Age, BMI, prostate volume, Charlson comorbidity index (CCI) score, pathological stage, ASA score, preoperative albumin, creatinine and hematocrit (HCT) were analysed for correlation with operative difficulty, indicated by OT, EBL and length of HS. The association of perioperative outcomes (complications or major complications, operative difficulty, mortality and PSM) with age, BMI, prostate volume, CCI score groups (i.e. < 5 indicates low or moderate comorbidity and ≥ 5 indicates high comorbidity), ASA score, preoperative albumin, creatinine, HCT and extravesical disease were analysed with using Pearson’s chi-squared test, Fisher's exact test, independent samples t-test and Mann–Whitney U tests. For categorical variables, Pearson chi-squared or Fisher's exact test were used. For continuous variables, in cases where normality criteria existed, an independent samples t-test was performed; otherwise, the Mann–Whitney U test was used. Independent predictors of operative difficulty and postoperative outcomes were investigated using multivariate linear and logistic regression analyses. Age, BMI, ASA score, prostate volume, CCI score, pathological stage and pelvic dimensions were included in the regression analyses.
An intraclass correlation test was used to evaluate the concordance of multiple measurements obtained from the same patient, and good agreement was obtained (intraclass correlation coefficient > 0.750, p < 0.001). Statistical significance was assumed at p < 0.05. The standard effect size was set to 0.54 with an sample of 79 patients and a 5% standard error (a) margin. Based on these calculations, the study power was found to be 99% effect (1-b) to providing sufficient data. Statistical significance was considered at p < 0.05. Statistical analyses were performed using IBM SPSS Statistics for Windows (version 21.0, IBM Corp., Armonk, NY, USA) and G*Power for Windows (version 3.1.9.7, Heinrich-Heine-Universität, Düsseldorf, Germany).

Results

Patients characteristics and complication types

The patients’ mean age was 68.25 ± 9.71 years. Clinical features, preoperative and postoperative results, pelvic dimensions and pathological evaluations of the patients are shown in Table 1. While complications were observed in 8 patients perioperatively (e.g. rectum injury, etc.), a total of 96 complications were observed in 52 of the 79 patients (65.8%) within 90 days of RC. The most common complication category was complications of the gastrointestinal system, appearing in 35.4% (n:28) of the cases, followed by infectious complications with 27.8% (n:22) and wound/skin complications with 21.5% (n:17). Ileus was the most common complication in 21 patients (26.5%) (Supplementary Table 1).
Table 1
Clinical features, preoperative and postoperative findings, pelvic dimensions and pathological results
 
Mean ± SD
Median (Min–Max)
Age ( year)
68.25 ± 9.71
69 (29–93)
BMI ( kg/m2)
25.96 ± 3.19
26.50 (19–35,1)
Prostate volume (cc)
47.94 ± 25.40
42 (20–168)
HGB (g/dL)
12.01 ± 1.58
12 (9–15.60)
HCT (%)
35.81 ± 4.60
35.60 (27–46.80)
Creatinine (mg/dL)
1.22 ± 0.53
1.10 (0.6–3.5)
Albumin (g/L)
3.52 ± 0.61
3.6 (2.3–4.5)
Operation time (min)
322 ± 76.96
320 (169–551)
Hospital stay (day)
11.93 ± 6.58
11 (4–49)
Estimated blood loss (mL)
1356.96 ± 514.88
1250 (500–3000)
Pelvic Dimensions
 UC
10.17 ± 0.79
10.14 (8.29–11.90)
 LC
11.02 ± 0.89
11.20 (9.11–13.07)
 PD
11.81 ± 0.85
11.80 (9.71–13.49)
 AD
3.19 ± 0.40
3.12 (2.33–3.97)
 SA
41.99 ± 5.36
41.09 (29.89–57.64)
 ISD
8.93 ± 0.65
8.81 (7.33–10.60)
 BFW
10.15 ± 0.53
10.09 (9.07–11.80)
 SW
4.60 ± 0.36
4.63 (3.54–5.79)
 ISD index
2.86 ± 0.41
2.85 (2.02–4.04)
 BFW index
3.25 ± 0.44
3.21 (2.45–4.85)
 SW index
1.47 ± 0.22
1.46 (1.03–2.33)
 
n
%
ASA Score
 2
35
44.3
 3
43
54.4
 4
1
1.3
Charlson score
 < 5
54
68.4
 ≥ 5
25
31.6
Pathological stage
  
 pTa + PTcis
10
12.7
 pT1
4
5.1
 pT2
22
27.8
 pT3
24
30.4
 pT4
17
21.5
 Excluding TCC
2
2.5
Lymph node
 N0
52
65.8
 N1
17
21.5
 N2
10
12.7
Clavien-Dindo classification
 Minor Complication (Grade 0–2)
30
38
 Major Complication (Grade 3–5)
22
27.8
 90-day mortality (Grade 5 complication)
11
13.9
 Prior abdominal surgery
7
8.9
 Perioperative complication
8
10.1
 Postoperative complication
52
65.8
 Perioperative transfusion
25
31.6
 Surgical margin positivity
11
13.9
SD Standard deviation, ASA American Society of Anesthesiologists, BMI Body Mass Index, CİS Carsinoma in situ, HGB Hemoglobin, HCT Hematocrit, UC Upper conjugate, LC Lower conjugate, PD Pelvic depth, AD Apical depth, SA Symphysis angle, ISD Interspinous distance, BFW Bony femoral width, SW Soft tissue width, TCC Transitional cell carcinoma
Major complications were observed in 22 patients (27.8%), of which 7 (8.9%) were grade 3 and 4 (5.1%) were grade 4. Eleven patients (13.9%) died within 90 days after the surgery, and 11 died of cardiopulmonary events (myocardial infarction, pulmonary embolism or respiratory failure). Eleven patients (13.9%) had PSMs.

Relationship between pelvic dimensions and perioperative outcomes

Among the operative difficulty parameters, OT was found to be correlated with BMI (p: < 0.001, r:0.620) and SA (p:0.011, r:-0.285). High SA values were related to short OT. EBL was found to be correlated with preoperative HCT (p:0.022, r:0.257) and LC (p:0.047, r:-0.225). Less EBL was related to higher LC values. No correlation was found between HS and other variables, including pelvic dimensions, BMI and CCI score. HS was not included in the regression analysis.
Linear regression analyses were performed to examine the factors affecting OT and EBL. Statistically related variables were included in the multiple linear regression analyses. The results, as shown in Table 2, indicate that preoperative HCT measurement was an independent predictor of EBL. It is intriguing that OT was longer if the patient had a narrow SA (p:0.006) and high BMI (p: < 0.001). However, other pelvic dimensions were found to have no significant relationship with OT.
Table 2
Factors affecting operation time and estimated blood loss. Operation time (F = 30.251, p (model) < 0.001, Adjusted R2 = 0.429); Estimated blood loss (F = 4.563, p (model) = 0.013, Adjusted R2 = 0.084)
Operation time
Independent variable
Beta
t
p
 Constant
-
1.187
0.203
 BMI
0.630
7.029
< 0.001
 SA
-0.244
-2.841
0.006
Estimated blood loss
Independent variable
Beta
t
p
 Constant
-
1.985
0.051
 LC
-0.203
-1.870
0.065
 Pre-operative HCT
0.239
2.198
0.031
BMI Body Mass Index, HCT Hematocrit, LC Lower conjugate, SA Symphysis angle

Relationship between pelvic dimensions and postoperative outcomes

There was no statistically significant relationship between mortality and pelvic dimensions, and a statistically significant relationship was found only between mortality and CCI score (p:0.011). A statistically significant relationship was found between LC measurement and incidence of major complications (p:0.024), with the incidence of major complications increasing with high mean LC values. BMI and high CCI were tended to be significant for major complications. A statistically significant relationship were found to exist between PSM and ASA score, prostate volume, preoperative albumin, CCI score and ISD index (all with p: < 0.05) The mean ISD index measurement of patients with PSM was found to be lower than that of patients with negative surgical margins. No difference in pelvic dimensions and other variables was found among patients who were readmitted to the hospital within 30 days of surgery.
Regression analysis was used to predict minor or major complications and PSM, as shown in Table 3. No statistically significant relationship was found between pelvic dimensions and minor or major complications. Further statistical tests revealed that pathological stage, high CCI score, and ISD index measurement were independent predictors of PSM. The most striking finding was that the risk of PSM was higher in patients with low ISD index value, narrow pelvis and deep prostate apex.
Table 3
Multivariate analysis of various factors potentially affecting presence of complication, major complication, 90-day mortality and positive surgical margin
Complication
OR (%95 CI)
p
 LC
0.542 (0.284–1.034)
0.063
 ISD index
0.577 (0.037–8.996)
0.695
 BFW index
4.868 (0.335–70.752)
0.246
 BMI
1.176 (0.986–1.403)
0.072
 Charlson comorbidity group (score ≥ 5)
4.197 (1.118–15.756)
0.034
 ASA score
1.351 (0.443–4.122)
0.597
 Clinical LN status
2.927 (0.764–11.217)
0.117
 Pathological stage
1.057 (0.656–1.702)
0.821
Major complication
OR (%95 CI)
p
 AD
2.664 (0.730–9.717)
0.138
 ISD index
0.444 (0.033–5.971)
0.540
 Charlson comorbidity group (score ≥ 5)
3.357 (1.009–11.169)
0.048
 Clinical LN status
0.638 (0.166–2.447)
0.512
 Pathological stage
1.634 (0.943–2.833)
0.080
 LC
1.754 (0.889–3.463)
0.105
 BMI
1.288 (1.032–1.608)
0.025
 ASA score
2.664 (0.730–9.717)
0.138
Mortality within 90 day
OR (%95 CI)
p
 AD
0.673 (0.014–32.028)
0.841
 ISD index
0.066 (0.001–4.264)
0.201
 LC
1.781 (0.576–5.501)
0.316
 UC
1.245 (0.411–3.771)
0.698
 Charlson comorbidity group (score ≥ 5)
11.492 (1.679–78.645)
0.013
 BMI
1.252 (0.874–1.794)
0.220
 Perioperative complication
4.492 (0.408–49.498)
0.220
 Pathological stage
1.555 (0.721–3.351)
0.260
 Clinical LN status
1.220 (0.146–10.229)
0.854
Positive surgical margin
OR (%95 CI)
p
 ISD index
0.022 (0.001–0.524)
0.018
 Pathological stage
12.824 (2.619–62.806)
0.002
 Charlson comorbidity group (score ≥ 5)
7.563 (1.008–56.722)
0.049
AD Apical depth, ASA American Society of Anesthesiologists, BMI Body Mass Index, LC Lower conjugate, LN Lymph node, SA Symphysis angle, UC Upper conjugate

Discussion

RC, is a morbid procedure with a high postoperative complication rate, frequent hospital readmissions and significant perioperative mortality risk [13]. The rate of complications within 90 days after RC and urinary diversion has been reported by various publications as 19.0–69.6% [1417], and mortality rates have been reported in the range of 2.3–9.0% [1821]. The overall 90-day postoperative complication and mortality rates in this study were 65.8% and 13.9%, respectively.
Only 27.8% (n = 22) of the patients in this study had pT2 stage BC. Furthermore, the cancer of 30.4% (n = 24) of the patients was upstaging to pT3 and that of 21.5% (n = 17) was upstaging to pT4. Thus,the it mortality rate of the patients in this study was relatively high. In a study by May et al. [22], 35% of patients diagnosed with pT1 cancer were found to have upstaging in their pathology after RC. As a result, the authors suggested that the cancer in patients in the high-risk group may be necessitating prompt operation.
A narrow, deep pelvis or the presence of the prostate at the base of the pelvis are also important considerations in the performance of a RC, such as RP, as both are linked to a higher incidence of postoperative complications and a technically challenging operation [12]. Measurements such as PD, AD, SA may play a role in manipulations during RC, such as deep dorsal vein ligation, apical dissection and the cutting of the lateral pedicles. In addition, pelvic dimensions may impact pelvic lymph node dissection in the obturator fossa [12]. Likewise, a wide and shallow pelvis may be preferable compared to a narrow and deep pelvis by surgeons [12]. All these considerations, it can be called the operative diffuculty.
Various publications have investigated whether pelvic anatomy plays a role in operative difficulty and complications of RP [7, 8, 23]. However, publications concerning the sames for RC are limited. In reference to general surgery, Boyle et al. stated that pelvic size might affect the difficulty of operation in colorectal surgery, finding that patients with smaller pelvic sizes are more likely to have PSM [24]. Likewise, Hong et al. suggested that pelvic dimensions may affect the difficulty of performing open and laparoscopic RP. The use of magnetic resonance imaging (MRI) allowed for a new measurement parameter called the pelvic dimension index (PDI) which can be used to calculate the ISD/AD ratio or ISD index in that low PDI values indicate a narrow and deep pelvis and high PDI values indicate a wide and shallow pelvis [7]. The same study found BMI to be independently associated the OT of open retropubic RP, and while pelvic size does not significantly affect the OT retropubic RP as much as patient-related factors such as BMI or prostate volume, it may have partial effect [7]. Hong et al. noted that the available working area in robot-assisted RP could be estimated using the pelvic cavity index (PCI) and that the dimensions of the pelvis did not affect the difficulty of robot-assisted RP in Korean patients [8]. Another prior study found pelvic dimensions to be correlated with OT and EBL [12]. Using, multivariate analysis, the same study determined that pelvic dimensions do not affect the difficulty of an RC but BMI and pathological stage may affect [12].
Contrary to the findings mentioned above, Mason et al. found that a deep and narrow pelvis might be associated with long OT and increased EBL in robot-assisted RP [23]. Similarly, Yao et al. reported that prostate volume/PCI ratio was a statistically significant predictor of console time and EBL in multiple linear regression analyses concluding that the OT of a procedure on a patients with large prostate volume and a small pelvis is prolonged, adding to the difficulty of the surgery [11]. The current study called these indicators as technical difficulty for RC: OT, perioperative EBL and HS. The multivariate regression analysis performed for OT, obtained results similar to those of the studies discussed above BMI and SA measurement were found to have an impact and that preoperative HCT was found to have an effect on EBL. According to the findings obtained in the present study, a narrow pelvis might cause difficulty in RC, albeit in a limited capacity.
In a study of 88 patients in a general surgery clinic, Boyle et al. found female patients with positive circumferential resection margins after colorectal surgery to have a significantly shorter ISD compared to those with negative circumferential resection margins and that preoperative measurement of ISD taken using MRI could affect the choice of adjuvant treatment [24]. A study by Matikainen et al. also involved the use of preoperative MRI to determine the effect of AD on RP. The authors reported AD to be a significant predictor of apical PSM, independent of the surgical approach and other clinicopathological variables [9]. In the current study, we found pathological T stage, high CCI score and ISD index to be independent risk factors for PSM. This result may be explained by the fact that the risk of PSM is higher in patients with a small ISD index value, narrow pelvis and deep prostate apex.
Surgical site infection (SSI) is a widespread postoperative complication that causes significant pain and suffering. SSI associated with negative economic effects, increased morbidity, extended postoperative HS, readmission, sepsis, and death [25]. Previous research has established that postoperative SSI is diagnosed in (21.8%) cases [25]. Moreover, SSIs following a procedure to treat colorectal cancer has been found to be significantly more common among patients that are older (> 70 years), obese (≥ 30 kg/m2), have ASA scores ≥ 3, have diabetes and with a history of chronic steroid use, undergoing open, dirty or contaminated surgery [25]. In our study, SSI was observed in 12 patients (15.1%).
Thus, evaluating a patient’s pelvic anatomy before a RC may help predict postoperative results, allowing for preparation for the possible difficulties of the procedure and more successful outcomes.

Limitations of the study

The limitations of the present study include its retrospective nature, short follow-up times and relatively small sample size.

Conclusion

The aim of this research was to examine preoperative predictions of postoperative complications in patients undergoing RC. The primary finding of this study was that SA is an independent predictor of OT, suggesting that surgeons may experience more difficulty performing a RC procedure on the patients with a narrow SA.
The second major finding was that the risk of PSM increased in patients with a narrow and deep pelvis. This suggests that ISD/AD ratio is a significant predictor of PSM and this relationship is independent of patient-related and other clinicopathological variables. Furthermore, the results of this study suggest that other anatomical variations in the pelvis may not be essential factors in terms of operative difficulty or minor or major complications. While patient-related features, such as CCI score and BMI, may increase mortality. This is the first study to present evidence for the pelvic dimensions of PSM in RC.

Acknowledgements

Not applicable.

Declarations

The present study protocol was reviewed and approved by the Institutional Review Board of Sakarya University College of Medicine (approval Number through 00384, 4 June 2020). The study followed the ethical principles of the Declaration of Helsinki. Informed consent was obtained by all subjects when they were enrolled.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Sun M, Trinh Q-D. Diagnosis and Staging of Bladder Cancer. Hematol Oncol Clin North Am. 2015;29(2):205–18.CrossRefPubMed Sun M, Trinh Q-D. Diagnosis and Staging of Bladder Cancer. Hematol Oncol Clin North Am. 2015;29(2):205–18.CrossRefPubMed
2.
Zurück zum Zitat Herr HW, Dotan Z, Donat SM, et al. Defining optimal therapy for muscle invasive bladder cancer. J Urol. 2007;177(2):437–43.CrossRefPubMed Herr HW, Dotan Z, Donat SM, et al. Defining optimal therapy for muscle invasive bladder cancer. J Urol. 2007;177(2):437–43.CrossRefPubMed
3.
Zurück zum Zitat Froehner M, Brausi MA, Herr HW, et al. Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol. 2009;56(3):443–54.CrossRefPubMed Froehner M, Brausi MA, Herr HW, et al. Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol. 2009;56(3):443–54.CrossRefPubMed
4.
Zurück zum Zitat Gamé X, Soulié M, Seguin P, et al. Radical cystectomy in patients older than 75 years: assessment of morbidity and mortality. Eur Urol. 2001;39(5):525–9.CrossRefPubMed Gamé X, Soulié M, Seguin P, et al. Radical cystectomy in patients older than 75 years: assessment of morbidity and mortality. Eur Urol. 2001;39(5):525–9.CrossRefPubMed
5.
Zurück zum Zitat Knap MM, Lundbeck F, Overgaard J. Early and late treatment-related morbidity following radical cystectomy. Scand J Urol Nephrol. 2004;38(2):153–60.CrossRefPubMed Knap MM, Lundbeck F, Overgaard J. Early and late treatment-related morbidity following radical cystectomy. Scand J Urol Nephrol. 2004;38(2):153–60.CrossRefPubMed
6.
Zurück zum Zitat Dell’Oglio P, Tian Z, Leyh-Bannurah S-R, et al. Short-form Charlson comorbidity index for assessment of perioperative mortality after radical cystectomy. J Natl Compr Canc Netw. 2017;15(3):327–33.CrossRefPubMed Dell’Oglio P, Tian Z, Leyh-Bannurah S-R, et al. Short-form Charlson comorbidity index for assessment of perioperative mortality after radical cystectomy. J Natl Compr Canc Netw. 2017;15(3):327–33.CrossRefPubMed
7.
Zurück zum Zitat Hong SK, Chang IH, Han BK, et al. Impact of variations in bony pelvic dimensions on performing radical retropubic prostatectomy. Urology. 2007;69:907–11.CrossRefPubMed Hong SK, Chang IH, Han BK, et al. Impact of variations in bony pelvic dimensions on performing radical retropubic prostatectomy. Urology. 2007;69:907–11.CrossRefPubMed
8.
Zurück zum Zitat Hong SK, Lee ST, Kim SS, et al. Effect of bony pelvic dimensions measured by preoperative magnetic resonance imaging on performing robot-assisted laparoscopic prostatectomy. BJU Int. 2009;104:664–8.CrossRefPubMed Hong SK, Lee ST, Kim SS, et al. Effect of bony pelvic dimensions measured by preoperative magnetic resonance imaging on performing robot-assisted laparoscopic prostatectomy. BJU Int. 2009;104:664–8.CrossRefPubMed
9.
Zurück zum Zitat Matikainen MP, von Bodman CJ, Secin FP, et al. The depth of the prostatic apex is an independent predictor of positive apical margins at radical prostatectomy. BJU Int. 2010;106(5):622–6.CrossRefPubMed Matikainen MP, von Bodman CJ, Secin FP, et al. The depth of the prostatic apex is an independent predictor of positive apical margins at radical prostatectomy. BJU Int. 2010;106(5):622–6.CrossRefPubMed
10.
Zurück zum Zitat Von Bodman C, Matsushita K, Matikainen MP, et al. Do pelvic dimensions and prostate location contribute to the risk of experiencing complications after radical prostatectomy? BJU Int. 2011;108(10):1566–71.CrossRef Von Bodman C, Matsushita K, Matikainen MP, et al. Do pelvic dimensions and prostate location contribute to the risk of experiencing complications after radical prostatectomy? BJU Int. 2011;108(10):1566–71.CrossRef
11.
Zurück zum Zitat Yao A, Iwamoto H, Masago T, et al. Anatomical dimensions using preoperative magnetic resonance imaging: impact on the learning curve of robot-assisted laparoscopic prostatectomy. Int J Urol. 2015;22(1):74–9.CrossRefPubMed Yao A, Iwamoto H, Masago T, et al. Anatomical dimensions using preoperative magnetic resonance imaging: impact on the learning curve of robot-assisted laparoscopic prostatectomy. Int J Urol. 2015;22(1):74–9.CrossRefPubMed
12.
Zurück zum Zitat Özkaptan O, Balaban M, Sevinc C, et al. Pelvic dimensions do not impact on complications and operative difficulty in radical cystoprostatectomy and orthotopic neobladder. Minerva Urol Nefrol. 2019;71(4):386–94.CrossRefPubMed Özkaptan O, Balaban M, Sevinc C, et al. Pelvic dimensions do not impact on complications and operative difficulty in radical cystoprostatectomy and orthotopic neobladder. Minerva Urol Nefrol. 2019;71(4):386–94.CrossRefPubMed
13.
Zurück zum Zitat Moschini M, Simone G, Stenzl A, et al. Critical review of outcomes from radical cystectomy: can complications from radical cystectomy be reduced by surgical volume and robotic surgery? Eur Urol Focus. 2016;2(1):19–29.CrossRefPubMed Moschini M, Simone G, Stenzl A, et al. Critical review of outcomes from radical cystectomy: can complications from radical cystectomy be reduced by surgical volume and robotic surgery? Eur Urol Focus. 2016;2(1):19–29.CrossRefPubMed
14.
Zurück zum Zitat Studer UE, Burkhard FC, Schumacher M, et al. Twenty years experience with an ileal orthotopic low pressure bladder substitute—lessons to be learned. J Urol. 2006;176:161–6.CrossRefPubMed Studer UE, Burkhard FC, Schumacher M, et al. Twenty years experience with an ileal orthotopic low pressure bladder substitute—lessons to be learned. J Urol. 2006;176:161–6.CrossRefPubMed
15.
Zurück zum Zitat Shabsigh A, Korets R, Vora KC, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55(1):164–76.CrossRefPubMed Shabsigh A, Korets R, Vora KC, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55(1):164–76.CrossRefPubMed
16.
Zurück zum Zitat Hautmann RE, de Petriconi RC, Volkmer BG. Lessons learned from 1,000 neobladders: the 90-day complication rate. J Urol. 2010;184(3):990–4.CrossRefPubMed Hautmann RE, de Petriconi RC, Volkmer BG. Lessons learned from 1,000 neobladders: the 90-day complication rate. J Urol. 2010;184(3):990–4.CrossRefPubMed
17.
Zurück zum Zitat Erber B, Schrader M, Miller K, et al. Morbidity and quality of life in bladder cancer patients following cystectomy and urinary diversion: a single-institution comparison of ileal conduit versus orthotopic neobladder. ISRN Urol. 2012;2012:1–8.CrossRef Erber B, Schrader M, Miller K, et al. Morbidity and quality of life in bladder cancer patients following cystectomy and urinary diversion: a single-institution comparison of ileal conduit versus orthotopic neobladder. ISRN Urol. 2012;2012:1–8.CrossRef
18.
Zurück zum Zitat Konety BR, Allareddy V, Herr H. Complications after radical cystectomy: analysis of population-based data. Urology. 2006;68(1):58–64.CrossRefPubMed Konety BR, Allareddy V, Herr H. Complications after radical cystectomy: analysis of population-based data. Urology. 2006;68(1):58–64.CrossRefPubMed
19.
Zurück zum Zitat Fairey A, Chetner M, Metcalfe J, et al. Associations among age, comorbidity and clinical outcomes after radical cystectomy: results from the Alberta Urology Institute radical cystectomy database. J Urol. 2008;180:128–34, discussion 134.CrossRefPubMed Fairey A, Chetner M, Metcalfe J, et al. Associations among age, comorbidity and clinical outcomes after radical cystectomy: results from the Alberta Urology Institute radical cystectomy database. J Urol. 2008;180:128–34, discussion 134.CrossRefPubMed
20.
Zurück zum Zitat Boström PJ, Kössi J, Laato M, et al. Risk factors for mortality and morbidity related to radical cystectomy. BJU Int. 2009;103(2):191–6.CrossRefPubMed Boström PJ, Kössi J, Laato M, et al. Risk factors for mortality and morbidity related to radical cystectomy. BJU Int. 2009;103(2):191–6.CrossRefPubMed
21.
Zurück zum Zitat Aziz A, May M, Burger M, et al. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European Multicenter Cohort. Eur Urol. 2014;66(1):156–63.CrossRefPubMed Aziz A, May M, Burger M, et al. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European Multicenter Cohort. Eur Urol. 2014;66(1):156–63.CrossRefPubMed
22.
Zurück zum Zitat May M, Bastian PJ, Brookman-May S, et al. Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder. Scand J Urol Nephrol. 2011;45(4):251–7.CrossRefPubMed May M, Bastian PJ, Brookman-May S, et al. Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder. Scand J Urol Nephrol. 2011;45(4):251–7.CrossRefPubMed
23.
Zurück zum Zitat Mason BM, Hakimi AA, Faleck D, et al. The role of preoperative endorectal coil magnetic resonance imaging in predicting surgical difficulty for robotic prostatectomy. Urology. 2010;76(5):1130–5.CrossRefPubMed Mason BM, Hakimi AA, Faleck D, et al. The role of preoperative endorectal coil magnetic resonance imaging in predicting surgical difficulty for robotic prostatectomy. Urology. 2010;76(5):1130–5.CrossRefPubMed
24.
Zurück zum Zitat Boyle KM, Petty D, Chalmers AG, et al. MRI assessment of the bony pelvis may help predict resectability of rectal cancer. Colorectal Dis. 2005;7(3):232–40.CrossRefPubMed Boyle KM, Petty D, Chalmers AG, et al. MRI assessment of the bony pelvis may help predict resectability of rectal cancer. Colorectal Dis. 2005;7(3):232–40.CrossRefPubMed
25.
Zurück zum Zitat Panos G, Mulita F, Akinosoglou K, Liolis E, Kaplanis C, Tchabashvili L, Vailas M, Maroulis I. Risk of surgical site infections after colorectal surgery and the most frequent pathogens isolated: a prospective single-centre observational study. Med Glas. 2021;18(2):438–43. Panos G, Mulita F, Akinosoglou K, Liolis E, Kaplanis C, Tchabashvili L, Vailas M, Maroulis I. Risk of surgical site infections after colorectal surgery and the most frequent pathogens isolated: a prospective single-centre observational study. Med Glas. 2021;18(2):438–43.
Metadaten
Titel
Can pelvic diameter measurement have an effect on surgical outcomes in radical cystectomy?
verfasst von
Anil Erdik
Haci Ibrahim Cimen
Osman Kose
Omer Faruk Ates
Onur Taydas
Deniz Gul
Hasan Salih Saglam
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Urology / Ausgabe 1/2023
Elektronische ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-023-01277-8

Weitere Artikel der Ausgabe 1/2023

BMC Urology 1/2023 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.